文摘
This is the first demonstration of the use of accelerator mass spectrometry (AMS) as a toolfor the measurement of 3H with attomole (10-18 mol) sensitivity in a biological study. AMS isan analytical technique for quantifying rare isotopes with high sensitivity and precision andhas been most commonly used to measure 14C in both the geosciences and more recently inbiomedical research. AMS measurement of serially diluted samples containing a 3H-labeledtracer showed a strong correlation with liquid scintillation counting. The mean coefficient ofvariation of 3H AMS based upon the analysis of separately prepared aliquots of these sampleswas 12%. The sensitivity for 3H detection in tissue, protein, and DNA was approximately2-4 amol/mg of sample. This high sensitivity is comparable to detection limits for 14C-labeledcarcinogens using 14C AMS and demonstrates the feasibility of 3H AMS for biomedical studies.One application of this technique is in low-dose, dual-isotope studies in conjunction with 14CAMS. We measured the levels of 3H-labeled 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine(PhIP) and 14C-labeled 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in rat livertissue and bound to liver DNA and protein 4.5 h following acute administration of individualor coadministered doses in the range of 4-5100 pmol/kg of body weight. Levels of PhIP andMeIQx in whole tissue and bound to liver protein were dose-dependent. MeIQx-protein and-DNA adduct levels were higher than PhIP adduct levels, which is consistent with theirrespective carcinogenicity in this organ. Coadministration of PhIP and MeIQx did notdemonstrate any measurable synergistic effects compared to administration of these compoundsindividually. These studies demonstrate the application of AMS for the low-level detection of3H in small biological samples and for its use in conjunction with 14C AMS for dual-labelingstudies.